ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Cybin Announces Overnight Marketed Public Offering of Common Shares firstwordpharma
July 28, 2021Cybin Inc. is pleased to announce that it has launched an overnight marketed public offering of common shares in the capital of the Company (the "Shares") at a price per Share and for aggregate gross proceeds to be determined in the context of the market. -
Cybin to Leverage Catalent’s Zydis for Psychiatric Drug contractpharma
March 23, 2021To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders. -
CYBIN signs agreement to acquire Adelia Therapeutics pharmaceutical-business-review
December 10, 2020Cybin announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc. for up to CDN$20,161,575 (approximately $15.75m) in an all-stock transaction.
Pharma Sources Insight January 2025
